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The small G protein family Rac has numerous regula-
tors that integrate extracellular signals into tight
spatiotemporal maps of its activity to promote spe-
cific cell morphologies and responses. Here, we
have generated a mouse strain, Rac-FRET, which
ubiquitously expresses the Raichu-Rac biosensor.
It enables FRET imaging and quantification of
Rac activity in live tissues and primary cells with-
out affecting cell properties and responses. We
assessed Rac activity in chemotaxing Rac-FRET
neutrophils and found enrichment in leading-edge
protrusions and unexpected longitudinal shifts and
oscillations during protruding and stalling phases of
migration. We monitored Rac activity in normal or
disease states of intestinal, liver, mammary, pancre-
atic, and skin tissue, in response to stimulation or in-
hibition and upon genetic manipulation of upstream
regulators, revealing unexpected insights into Rac
signaling during disease development. The Rac-
FRET strain is a resource that promises to fundamen-
tally advance our understanding of Rac-dependent
responses in primary cells and native environments.
INTRODUCTION
The small G protein family Rac is an essential controller of actin
cytoskeletal dynamics and hence cell shape, adhesion, motility,
regulated secretion, and phagocytosis, as well as of gene
expression and reactive oxygen species (ROS) formation (Heas-
man and Ridley, 2008; Wennerberg et al., 2005). Rac is active
(i.e., able to bind downstream effectors) when guanosine
triphosphate (GTP)-bound and inactive when guanosine diphos-Cephate (GDP)-bound. Its activation is catalyzed by at least 20
different DBL- or DOCK-type guanine nucleotide exchange fac-
tors (GEFs) (Rossman et al., 2005) and its inhibition by an equally
large number of Rac-GTPase-activating proteins (GAPs). Rac
downstream signaling specificity and the ensuing Rac-depen-
dent cell responses are largely conferred through the types of
GEFs and GAPs that couple Rac to any given upstream signal
(Rossman et al., 2005).
Fo¨rster resonance energy transfer (FRET) technology is widely
used to monitor protein/protein interactions, coupling fluoro-
phore pairs such as cyan fluorescent protein (CFP) and yellow
fluorescent protein (YFP) to two proteins of interest. Inter- and in-
tramolecular FRET probes have been used for a decade to visu-
alize Rac activity (Aoki andMatsuda, 2009; Hodgson et al., 2010;
Itoh et al., 2002; Kraynov et al., 2000). Intermolecular Rac FRET
reporters measure the interaction between separate molecules
that must be expressed to comparable levels and subcellular
distributions (Kraynov et al., 2000), which can be technically diffi-
cult, and they are prone to interfere with endogenous GTPase
signaling (Aoki andMatsuda, 2009; Hodgson et al., 2010). The in-
tramolecular ‘‘Raichu’’ (Ras superfamily and interacting protein
chimeric unit) Rac-FRET probe contains RAC1 as the signal
sensor and Pak-CRIB as the effector, CRIB being the CDC42/
Rac interactive binding motif of Pak, a Rac target that binds to
GTP-bound, but not GDP-bound, Rac. In Raichu-Rac, RAC1-
GTP binding to Pak-CRIB causes FRET from CFP to YFP (Itoh
et al., 2002). The probe is anchored into the plasma membrane
via a KRAS CAAX motif and hence monitors the balance of
endogenous Rac-GEF and Rac-GAP activities at the physiolog-
ically relevant subcellular localization of active RAC1 (Itoh et al.,
2002).
Rac-FRET biosensors have largely been used in transfection-
based experiments in order to correlate the localization of
Rac activity with cellular function. Rac is required for cell motility,
and use of Rac-FRET probes showed that active Rac localizes to
extending cell protrusions during many fundamental processes,ll Reports 6, 1153–1164, March 27, 2014 ª2014 The Authors 1153
including the leading edge of migrating cells (Itoh et al., 2002;
Kraynov et al., 2000; Machacek et al., 2009; Ouyang et al.,
2008), forming phagosomal cups during phagocytosis of
apoptotic cells (Nakaya et al., 2008), distal poles of daughter
cells during cell division (Yoshizaki et al., 2003), or developing
neurites during neurogenesis (Aoki et al., 2004). Combining
Raichu-Rac expression with downregulation of Vav-family
Rac-GEFs showed that phosphatidylinositol 3-kinase-driven
GEFmembrane targeting localizes Rac activity during neurogen-
esis (Aoki et al., 2005). Expression of an intermolecular Rac-
FRET reporter combined with downregulation of the Rac-GEF
TIAM1 showed that TIAM1 association with distinct scaffolding
proteins directs localized Rac activity depending on extracellular
stimulus (Rajagopal et al., 2010). Similarly, overexpression of a
Raichu-Rac-like probe combined with membrane-targeting of
TIAM1 or the Rac-GAP chimaerin in Madin-Darby canine kidney
(MDCK) cell cysts showed mislocalization of Rac activity to suf-
fice for luminal invasion (Yagi et al., 2012a, 2012b). Finally, use of
Raichu-Rac demonstrated apicobasal Rac activity gradients
at epithelial cell junctions driven by differential regulation of
TIAM1 through b2-syntrophin and Par-3 (Mack et al., 2012).
Raichu-Rac-derived probes are also beginning to be used for
monitoring Rac activity in whole tissues. Reporter expression in
Xenopus and zebrafish embryos showed localized RAC1 activity
in migrating cells during organ development (Kardash et al.,
2010; Matthews et al., 2008; Xu et al., 2012). A limitation of these
studies was that biosensor expression was transient. The
first transgenic Rac-FRET biosensor organism was generated
recently, a fly that conditionally expresses modified Raichu-
Rac in border cells. This revealed Rac activity gradients not
only inside cells, but between cell clusters, being highest in cells
leading in the direction of migration (Wang et al., 2010). First use
of Raichu-Rac-like probes inmammals was recently achieved by
transplantation of biosensor-expressing glioblastoma cells into
rat brain, thus enabling correlation of Rac activity with the
mode of tumor cell migration during invasion (Hirata et al.,
2012). Whereas this study was limited by biosensor expression
in cultured rather than primary cells, it clearly demonstrated
that the mammalian tissue microenvironment controls Rac
activity (Hirata et al., 2012).
There is therefore a need for measuring Rac activity in primary
mammalian cells and tissues for assessing its regulation by
physiologically and functionally relevant organ- or disease-spe-
cific environmental cues. Here, we report the development of a
Rac-FRET mouse strain, which ubiquitously expresses the orig-
inal intramolecular Raichu-Rac reporter to allow spatiotemporal
quantification of Rac activity in living primary mammalian cells
and tissues.
RESULTS
Generation of the Rac-FRET Mouse
We generated a Rac activity reporter mouse strain by intro-
ducing the extensively validated intramolecular Raichu-Rac
FRET biosensor (Itoh et al., 2002) into the ROSA26 locus to
confer ubiquitous expression from the endogenous promoter.
To this end, we first generated Rac-FRETfl/fl, a strain in which
Raichu-Rac expression was conditionally prevented by a tran-1154 Cell Reports 6, 1153–1164, March 27, 2014 ª2014 The Authorsscriptional stop and crossed this with ‘‘deleter,’’ a strain with
X-chromosomalCre recombinase, to excise the stop and enable
constitutive Raichu-Rac expression before breeding out Cre
again (Figure S1). Homozygous knockin mice of the resulting
Rac-FRET strain were born at expected Mendelian ratio,
appeared healthy and fertile, lived normal life-spans, and ex-
hibited no untoward behaviors.
Raichu-Rac Expression Levels in Rac-FRETMouse Cells
and Tissues
Raichu-Rac expression was detected in all tissues tested, at
approximately 20–25 ng/mg of tissue, although expression in
muscle tissue (heart, stomach, and skeletal muscle) was some-
what lower, at 2–10 ng/mg (Figure 1A). In primary Rac-FRET neu-
trophils, which express equal amounts of ubiquitous RAC1 and
hematopoietic RAC2, expression of the biosensor was 0.6% of
endogenous RAC1 and RAC2 (Figure 1B), and in primary E13.5
Rac-FRET mouse embryonic fibroblasts (MEFs), it was 8% of
endogenous RAC1 (Figure 1C). Therefore, Raichu-Rac protein
levels are low compared to endogenous Rac, as we had aimed
for, in order to prevent possible dominant-negative effects. As
Raichu-Rac expression did not cause obvious defects and
Rac-FRET mice appeared healthy, we continued to characterize
properties and responses of primary Rac-FRET MEFs and neu-
trophils in detail to determine if it affected cell function.
Primary Rac-FRET MEFs Function Normally and Show
Highly Localized Rac Activity upon PDGF or Insulin
Stimulation
We investigated proliferation, lifespan, and morphology of pri-
mary Rac-FRET MEFs. They showed normal proliferation rates,
low cell death (2%–4%) in culture, and normal cell morphologies
upon serum starvation and platelet-derived growth factor
(PDGF) stimulation (Figures S2A–S2C). Pak-CRIB pull-down
assays showed that endogenous RAC1 activity was normal in
serum-starved and PDGF-stimulated Rac-FRET MEFs, as was
the activity of the Rac target p38MAPK (Figures S2D and S2E).
Rac-FRET MEFs were assessed by ratiometric FRET imaging,
where increases in YFP/CFP fluorescence ratio induced by FRET
reflect increased Rac activity. Treatment with 50 ng/ml PDGF
stimulated the formation of lamellipodial protrusions and periph-
eral membrane ruffles, which showed significantly higher Rac
activity (FRET ratio of 1.25) than cell edges without protrusions
(FRET ratio of 1.1), and Rac activity remained high throughout
lamellipodia formation and ruffling (Figures 2A and 2B; Movie
S1). Therefore, Rac activity correlated spatially and temporally
with lamellipodia and ruffles, as expected from studies in
fibroblast-like cell lines (Itoh et al., 2002). Stimulation with
100 mg/ml insulin, which caused larger lamellipodia but fewer
dorsal ruffles, gave similar results (Figure 2C; Movie S2).
Rac-FRETNeutrophils FunctionNormally andShowHigh
Rac Activity during Spreading and Polarization
We and others have previously shown that Rac and its upstream
regulators play crucial roles in ROS formation, adhesion,
spreading, and chemotaxis of neutrophils (Deng et al., 2011;
Gu et al., 2003; Lawson et al., 2011; Roberts et al., 1999; Welch
et al., 2002, 2005), but analysis of Rac activity in these cells has
Figure 1. Raichu-Rac Expression Level in
Tissues and Primary Cells of the Rac-FRET
Mouse Strain
(A) Whole-tissue lysates were prepared from adult
Rac-FRET mice and blotted with anti-GFP anti-
body alongside recombinant CFP standards to
reveal the CFP portion of Raichu-Rac. a.u., arbi-
trary units; WT, wild-type.
(B) Raichu-Rac expression levels in total lysates
of the indicated numbers of diisopropyl fluo-
rophosphate-treated Rac-FRET neutrophils were
determined by western blotting alongside recom-
binant RAC1 and CFP standards using anti-RAC1
AB (green) and anti-GFP AB (red) to compare
biosensor expression with endogenous RAC1.
(C) Raichu-Rac expression levels in total lysates of
the indicated numbers of Rac-FRET MEFs were
determined by western blotting alongside recom-
binant RAC1 and CFP standards with antibodies
as in (B).been hampered by the facts that they are short-lived and cannot
easily be transfected. Here, we determined if Rac-dependent
neutrophil responses are affected by Raichu-Rac expression.
Rac-FRET neutrophils developed normally in the bone marrow
(not shown), mounted normal ROS responses to the G protein
coupled receptor ligand N-formyl-methionyl-leucyl-phenylala-
nine (fMLP) and to phorbol myristate acetate (PMA), adhered
normally to glass or the integrin ligand poly-Arg-Gly-Asp, spread
normally, and underwent normal basal migration and fMLP-
stimulated chemotaxis in transwell assays, whereas Rac2/
cells showed the expected defects (Figures S3A–S3D; Lawson
et al., 2011; Roberts et al., 1999). Furthermore, the basal and
fMLP-stimulated activities of endogenous RAC1 and RAC2 (by
Pak-CRIB pull-down assays) and of the Rac target p38MAPK
were normal (Figures S3E–S3G). Therefore, Rac-FRET neutro-
phil responses were normal by all measures tested.
Rac is required for neutrophil spreading and polarization (Gu
et al., 2003; Roberts et al., 1999). We assessed Rac activity
during these responses in Rac-FRET neutrophils in the presence
or absence of the Rac inhibitor NSC23766. Upon first contactCell Reports 6, 1153–1164with the coverslip (time 0), Rac activity
(normalized FRET ratio) was lower in
NSC23766-treated than control cells,
but increased initially in both upon adhe-
sion, reaching a maximal value of 1.23
within 8 min in control cells compared to
1.04 in NSC23766-treated cells, and
remained high throughout in control
cells whereas decreasing to 0.87 with
NSC23766 (Figures 3A and 3B). Control
cells spread from 90 to 130 mm2 within
8 min and remained spread, whereas
spreading was significantly dampened
by NSC23766 (Figure 3C). Rac activity re-
mained high in control cells, correlating
with their ability to start polarizing twice
as fast as NSC23766-treated cells, to
fully polarize and to maintain polarity (Fig-ure 3D). Hence, combined use of NSC23766 and ratiometric
FRET imaging showed that Rac activity is required for Rac-
FRET neutrophil spreading and polarization, that it increases
globally throughout the cell during spreading, and that it remains
elevated during polarization.
Rac Activity in Chemotaxing Rac-FRET Neutrophils
Chemotaxing primary murine neutrophils are fast-migrating cells
(up to 20 mm/min) that extend transient probing lamellipodial pro-
trusions at their front and sides that typically last for 1 s and
longer-lived protrusions (several seconds), mostly at the leading
edge, that result in translocation. Here, we assayed Rac activity
during chemotaxis of Rac-FRET neutrophils in fMLP gradients
(Figure 4A; Movie S3). Ratiometric FRET imaging at 1 s frame
intervals showed that high Rac activity correlated spatially with
lamellipodial protrusions and low Rac activity with membrane re-
tractions. Temporally, Rac activity was as transient as the protru-
sions (Figures 4A and 4B). We used polar plots to visualize the
localization of Rac activity over time. Comparison with rubber
band plots (which depict cell outlines over time) and cell path, March 27, 2014 ª2014 The Authors 1155
Figure 2. High Rac Activity in Lamellipodial Protrusions and Membrane Ruffles of PDGF-Stimulated Primary Rac-FRET MEFs
(A) Rac activity in PDGF-stimulated (50 ng/ml) Rac-FRET MEFs determined by ratiometric FRET live imaging. Frames were taken every 10 s (left: generation of
ratiometric image) and analyzed at protruding (top) and nonprotruding sections (bottom) along the cell edge (magnifications of boxes in the FRET image on the
left). Note that, for ratiometric FRET measurements, increase in FRET ratio equals increase in Rac activity.
(B) Quantification of mean Rac activity (FRET ratio ± SEM) in 88 basal and protruding sections along the cell edge of PDGF-stimulated Rac-FRET MEFs as in (A)
from 20 cells and three independent experiments. **p < 0.01 by paired Student’s t test.
(C) Rac activity in insulin-stimulated (100 mg/ml) Rac-FRETMEFs determined by ratiometric FRET imaging. Consecutive frames taken every 10 s, shown from 80 s
after addition of insulin (left: YFP/FRET and CFP images used to generate first ratiometric image). Arrow shows Rac activity at membrane ruffles.plots showed that Rac activity is highest at the leading edge and
that bursts of high Rac activity typically last for 3–5 s (Figures 4C,
S4A, and S4B). In addition to the leading edge, average polar
plots showed bursts of Rac activity at the periphery and trailing
edge (Figures S4C and S4D). Detailed analysis of the time
dependence of Rac activity and the speed of movement of the
cell edge by Pearson’s correlation showed a direct correlation
(height of peak) between the extent of Rac activity (FRET ratio)
and speed of protrusion formation, without any time lag in the
order of seconds (alignment of peak with lag = 0 s; Figures 4D
and S4E). Therefore, high Rac activity is spatially, temporally,
and inmagnitude tightly correlated with lamellipodial protrusions
at the leading edge of chemotaxing neutrophils.
Oscillations of Rac Activity between the Front and Back
of Chemotaxing Rac-FRET Neutrophils
To investigate the bursts of Rac activity at the front versus back
of chemotaxing neutrophils further, we line-scanned Rac activ-
ity along the central longitudinal axis at 1 s intervals and dis-
played it as a function of time in kymographs (Figure 4E). This
revealed that Rac activity (normalized FRET ratio) is higher at
the front of chemotaxing cells than at the back, as expected,
but furthermore that the bulk of Rac activity shifts by 1.6 mm
toward the posterior of the cell during stalling phases (Figures
4F and S4F). Plotting the location of peak Rac activity on the
longitudinal axis against time revealed unexpected oscillations1156 Cell Reports 6, 1153–1164, March 27, 2014 ª2014 The Authorsof Rac activity between the front and back of chemotaxing neu-
trophils, and albeit these oscillations being noisy, they tended
toward periodicity. Oscillations of peak Rac activity occurred
in all cells analyzed and ranged from 6 to 12 s (mean ± SEM =
8.7 ± 0.4 s), with R2 values (fit of oscillations to periodicity)
ranging from 0.4 to 0.9 (mean = 0.7; Figure 4G). The oscillating
peak Rac activity was significantly greater than mean whether
localized at the front or the back (Figure S4G). To assess
whether the oscillations of Rac activity are characteristic of
chemotaxis, we compared control and NSC23766-treated
neutrophils. As expected, NSC23766 inhibited chemotaxis (Fig-
ure S4Hi), and both mean and peak Rac activity along the cen-
tral longitudinal axis were lower in NSC23766-treated cells than
in control cells (Figure S4Hii). We categorized NSC23766-
treated cells that retained some form of movement into those
migrating directionally (toward the chemoattractant) and those
which had lost directionality (moving nondirectionally, antidirec-
tionally, or without translocation). Oscillations of Rac activity
were significantly perturbed in both categories compared to
control cells but more so in cells that had lost directionality,
as seen by the significant decreases in R2 value from 0.71 to
0.51 and 0.36, respectively (Figure S4Hiii). These results
confirmed that oscillations of Rac activity along the central lon-
gitudinal axis of the cell are a hallmark of directional migration in
primary mouse neutrophils. Therefore, the use of ratiometric
FRET imaging in primary Rac-FRET neutrophils has allowed
A B
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Figure 3. High Rac Activity during Spreading and Polarization of Rac-FRET Neutrophils
(A) Spatiotemporal distribution of Rac activity in Rac-FRET neutrophils during spreading and polarization on glass coverslips was determined by ratiometric FRET
live imaging in the presence or absence of 75 mM NSC23766 (without preincubation), starting from the first point of contact of the cells with the coverslip.
Representative FRET ratio images are shown.
(B) Quantification of Rac activity (average cellular FRET ratio, normalized to control cells) in 69 control and 59 NSC23766-treated cells as in (A) from six inde-
pendent experiments ± SEM p < 0.0001 by ANOVA.
(C) Surface area of the cells in (B).
(D) Polarization of the cells in (B) was analyzed as: time to start polarizing (i), % of fully polarized cells (as defined by their ability to locomote) (ii), and % of cells
reverting to nonpolarized morphology over the 30 min of imaging (iii). *p < 0.05 by unpaired Student’s t test.us to reveal unexpected insights into the complexities of Rac
signaling during chemotaxis.
Spatiotemporal Regulation of Rac Activity in Mouse
Intestinal Crypt Cultures
To examine the spatiotemporal control of Rac activity in a multi-
cellular environment, we generated primary three-dimensional
(3D)-intestinal crypt cultures (Myant et al., 2013; Sato et al.,
2009) from the Rac-FRET mouse and analyzed them by fluores-
cence-lifetime imaging microscopy (FLIM)-FRET imaging, where
a decrease in CFP fluorescence lifetime due to FRET reflects
increased Rac activity. We could readily detect Raichu-Rac
expression and image Rac activity in these cultures, which re-
sponded to stimulation with 200 nM PMAwith a time-dependent
increase that peaked after 30min and subsided after 90min (Fig-
ures 5A and 5B). Rac activity was also spatially regulated. Basal
Rac activity was higher in cells at the base of the crypts than in
distal cells, and cells at the base of the crypts also responded
more strongly to PMA treatment than distal cells (Figures 5A
and 5B). This demonstrates reversible and spatial regulation of
Rac activity within multicellular mammalian environments, as
previously observed in Drosophila (Wang et al., 2010).CeEffects of Drug Treatment, Genetic Manipulation, and
Disease Development on Rac Activity In Vivo
We recently demonstrated that multiphoton microscopy can be
used for ex vivo and in vivo FLIM-FRET imaging of murine tumors
formed by implanted Raichu-RhoA-expressing pancreatic carci-
noma cells (Timpson et al., 2011) and that RHOA activity at the tip
of invading tumors correlates with invasion efficiency (McGhee
et al., 2011; Timpson et al., 2011). Here, we used similar imaging
techniques with the Rac-FRET mouse to examine Rac activity in
native host tissue.
Our recent work suggested that increased Rac activity
following loss of the tumor suppressor adenomatous polyposis
coli (APC) facilitates stem cell hyperproliferation at the base of in-
testinal crypts and colorectal cancer initiation via enhanced ROS
and nuclear factor (NF)-kB production (Myant et al., 2013). To
investigate this here, we first evaluated ex vivo multiphoton
FLIM-FRET imaging of Rac activity in normal intestinal tissue of
the Rac-FRET mouse. Rac activity could be measured within a
range of 0–150 mm from the base of crypts toward the villi and
was stimulated at the crypt base upon treatment with 200 nM
PMA (Figures 5C and 5D; Movie S4). We crossed the Rac-
FRET mouse to Vil-Cre-ERT2 APCfl/fl mice and induced intestinalll Reports 6, 1153–1164, March 27, 2014 ª2014 The Authors 1157
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Figure 4. High Rac Activity Correlates with Protrusion Formation at the Leading Edge and Oscillates between the Front and Back of
Chemotaxing Rac-FRET Neutrophils
(A) Ratiometric FRET live imaging of a representative Rac-FRET neutrophil chemotaxing toward 3 mM fMLP in an Ibidi chamber; images taken at 1 s intervals over
20 s (chemoattractant source is due south). For comparison of Rac activity with cell protrusions and retractions, cell perimeters at consecutive time points T (blue)
and T+1 s (red) were plotted using ImageJ plugin QuimP.
(legend continued on next page)
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APC loss by tamoxifen treatment (Myant et al., 2013) to assess
the APC dependence of Rac activity in crypts by in vivo FLIM-
FRET imaging. APC loss led to increased Rac activity at the
base of crypts in Vil-Cre-ERT2 APCfl/fl Rac-FRET mice (Figures
5E and 5F), thus demonstrating the utility of the Rac-FRET
mouse as a tool for examining the regulation of Rac during dis-
ease initiation.
Next, we examined Rac activity in the pancreas in the context
of the stromal extracellular matrix (ECM) at depth. Upon stimula-
tion of Rac-FRET mouse pancreas with 200 nM PMA ex vivo,
increased Rac activity was observed (Figures 6A and 6B; Movie
S5). We crossed the Rac-FRET mouse to the Kras+/G12D
Trp53+/R172HPdx1-Cre (KPC) model of pancreatic ductal adeno-
carcinoma, in which gain-of-function p53R172H drives metastasis
on a KRASG12D background (Morton et al., 2010; Muller et al.,
2009). In vivo FLIM-FRET imaging of pancreatic tumors in KPC
Rac-FRET mice compared to normal pancreas in Rac-FRET
mice revealed that Rac activity was significantly upregulated in
tumors (Figures 6C and 6D). Such deregulated Rac activity
may partially explain the disruption of cell-cell and cell-matrix
adhesion and tumor dissociation, which characterize this inva-
sive and highly metastatic model (Morton et al., 2010; Muller
et al., 2009, 2013).
We also crossed the Rac-FRET mouse to the locally invasive
Polyoma-middle T (PyMT) breast cancer model. Rac activity
could readily be detected in isolated primary mammary tumors
of PyMT Rac-FRET mice and inhibited by NSC23766 treatment
(Figures 7A and 7B; Movie S6). In vivo FLIM-FRET imaging of
exposed tumor tissue of PyMT Rac-FRET mice injected with
NSC23766 showed that Rac was inactivated within 60 min of
NSC23766 administration and began to revert to control level
after 90 min (Figures 7C and 7D). This highlights the utility of
the Rac-FRET mouse for monitoring drug target activity and
clearance rates, which could be applied to guide the scheduling
and dosing of therapeutic intervention.
Finally, we have recently shown that the Rac-GEF PREX1 is
deregulated in melanoma and drives Rac-dependent invasion
(Li et al., 2011; Lindsay et al., 2011). To assess whether the
Rac-FRET mouse is useful for examining Rac activity in the
skin, while at the same time trialling tissue-specific expression,(B) Enlargement of boxed sections shown in (A). The green-framed box shows
trailing edge.
(C) Polar plot of Rac activity (FRET ratio) around the perimeter of the cell shown i
starting in the center (1 s) and growing eccentrically outward over time.
(D) Pearson’s correlation between Rac activity (FRET ratio) at nodes around the ce
and cell edge velocity. FRET intensities were evaluated against edge speeds be
membrane protrusion/retraction speed. Red line shows average correlation from
3 mM fMLP over 100–120 s with images acquired every 1 s; gray traces show m
(E) Rac-FRET neutrophils chemotaxing toward 3 mM fMLP in an Ibidi chamber w
gitudinal axis, and Rac activity (FRET ratio) over time plotted as kymographs. Pro
achieved by averaging line scans for each segment (as detailed in Supplemental E
4.2 mm/min during stalling phases of migration.
(F) Average Rac activity (FRET ratio) in central longitudinal line scans of 25 cells fro
of the peak Rac activity from the front edge during protruding and stalling phases o
(mean of 25 cells; five experiments; paired t test p = 0.02).
(G) Rac activity oscillates between the front and the back of chemotaxing neu
representative chemotaxing neutrophil was plotted for each 1 s time frame in ord
activity over time, and best fit periodicity curves (purple) were applied to evaluate t
green, that of the back in red. Data shown are from one cell representative of 19
Cewe crossed Rac-FRETfl/fl to K14-Cre mice to induce selective
Raichu-Rac expression in keratinocytes. Rac activity could
readily be detected by FLIM-FRET imaging of E15.5 K14-Cre
Rac-FRETfl/fl embryonic skin explants and stimulated by PMA
treatment (Figure S5; Movie S7). Combined with PREX1 defi-
ciency, this may be useful for examining PREX1 in melanoma
metastasis. Collectively, the assessment of Rac activity within
these and other organs, such as the liver (Figure S6; Movie
S8), emphasizes the general utility and scope of the Rac-FRET
mouse as a tool for monitoring the intricate mechanisms of regu-
lation of Rac signaling in amyriad of physiological processes and
disease states.
DISCUSSION
Here, we report the development of a Rac-FRET mouse that
ubiquitously expresses Raichu-Rac. We examined Rac activity
in primary MEFs, neutrophils, and intestinal crypts, as well as in
intact tissues (intestine, liver, mammary, pancreas, and skin), in
response to genetic or drug intervention. This revealed unex-
pected insights into Rac signaling during neutrophil chemotaxis,
tissue homeostasis, disease initiation, and disease progression.
We chose the Raichu-Rac reporter over other Rac-FRET bio-
sensors as the probe most likely to provide best signal-to-noise
ratio without affecting cell survival. A similar Raichu-Rac probe
with a RAC1 instead of a KRAS membrane-targeting cassette
gives higher background (Yoshizaki et al., 2003); another probe
that uses CRIB between CFP and YFP, measuring FRET inhibi-
tion upon binding of endogenous Rac (Graham et al., 2001), is
neither as sensitive as Raichu-Rac nor specific for Rac, as it
also binds CDC42-GTP; and finally a Raichu-like probe in which
YFP is replaced with more sensitive YPet (Ouyang et al., 2008)
suggested nonnegligible cytotoxicity in our hands. Recently,
progress in the development of Raichu sensors involving longer
linkers in the reporter molecule has been made, reducing basal
FRET further and thus increasing signal-to-noise (Komatsu
et al., 2011). A next step in reporter mouse development could
be the use of such an improved construct.
The ROSA26 locus was chosen for its ubiquitous expression,
and the endogenous ROSA26 promoter, rather than strongera protrusion at the leading edge of the cell, the red box a retraction at the
n (A) over time; perimeters depicted as perfect circles, 1 circle/1 s time frame,
ll perimeter and 0.4 mm from the cell edge (schematic example shown in insert)
tween T5 s and T+5 s to test for time dependence between Rac activity and
seven independent experiments with a total of 133 cells chemotaxing toward
eans of individual experiments.
ere live imaged at 1 s intervals, line scans performed through the central lon-
filing of steep (protruding) versus flat (stalling) sections of the kymograph was
xperimental Procedures). Average speedwas 15 mm/min during protruding and
m five independent experiments. Gray and black dotted lines show the distance
f migration. The extent of the retrograde shift was 1.6 mmduring stalling phases
trophils. Maximum Rac activity (blue) along the central longitudinal axis of a
er to allow an assessment of the spatial localization of the point of highest Rac
he oscillations. The position of the front of the cell at each time point is traced in
cells analyzed.
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Figure 5. Spatiotemporal Distribution of Rac Activity in Intestinal Tissue
(A) PMA stimulation of Rac activity at the base is stronger than in distal cells of Rac-FRET duodenal crypt cultures. Representative fluorescence image of an
intestinal crypt culture (left) with Raichu-Rac (blue) and corresponding FLIM-FRET fluorescence lifetimemaps of Rac activity before (middle) or after (right) 200 nM
PMA treatment. In the FLIM-FRET images, arrows highlight the crypt base and insets show enlarged boxed sections. Note that, for FLIM-FRET measurements,
decrease in fluorescence lifetime equals increase in Rac activity.
(B) Quantification of Rac activity in intestinal crypt cultures as in (A) upon stimulation with 200 nM PMA for 0–90 min. Mean fluorescence lifetime ± SEM of 21–31
cells at varying positions in the base (black) or the distal section of the crypt (gray), as indicated by the schematics, for each time point and location. *p < 0.05,
***p < 0.001, and ****p < 0.0001 by unpaired Student’s t test between indicated time and 0-time control.
(C) Rac activity at the base of Rac-FRET intestinal crypts is stimulated by PMA ex vivo. Representative FLIM-FRET images before (left) and after (right) stimulation
of freshly isolated intestinal crypt tissue with 200 nM PMA for 15 min. For each pair of images, the left-hand panel shows a representative fluorescence image of
intestinal crypts expressing Raichu-Rac (blue), the right-hand one a corresponding fluorescence lifetime map.
(D) Quantification of Rac activity (fluorescence lifetime; mean ± SEM) at the base of 20 intestinal Rac-FRET mouse intestinal crypts before and after PMA
stimulation ex vivo as in (C).
(E) Rac activity at the base of intestinal crypts is increased upon tissue-specific APC loss in vivo. Representative FLIM-FRET images at the base of intestinal crypts
of live Vil-Cre-ERT2 Rac-FRET control mice (left) and Vil-Cre-ERT2 APCfl/fl Rac-FRET mice with intestinal tissue-specific APC deletion (right). For each pair of
images, the left-hand panel shows a representative fluorescence image of intestinal crypts expressing Raichu-Rac (blue) and the second harmonic generation
(SHG) signal from host ECM components (white), the right-hand one a corresponding fluorescence lifetime map.
(F) Quantification of Rac activity (fluorescence lifetime; mean ± SEM) from 206 cells at the base of intestinal crypts in control mice and 197 cells in APC-deleted
mice as in (E); three independent regions each. **p < 0.05 by unpaired Student’s t test.exogenous promoters, to deliberately aim for low expression
levels to prevent conceivable dominant-negative effects. We
introduced Raichu-Rac with a floxed stop cassette for either
ubiquitous or conditional expression, depending on the choice
of Cre-recombinase strain. The Rac-FRET mouse expresses
Raichu-Rac constitutively and ubiquitously. Our assessment
of MEFs and neutrophils showed that we gauged expression
level well, high enough for detection, but not affecting cell1160 Cell Reports 6, 1153–1164, March 27, 2014 ª2014 The Authorsproperties or responses. However, particularly in neutrophils,
signal strength is limiting, so development of a strain with
stronger inducible expression may be useful. Crossing of Rac-
FRETfl/fl to K14-Cre mice demonstrated that the conditional
Rac-FRETfl/fl strain is useful for tissue-specific expression of
Raichu-Rac. Such targeted expression of the reporter will allow
the assessment of Rac activity in specific cell types within het-
erogeneous tissues. For example, Lgr5-Cre mice (Barker et al.,
AC
B
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Figure 6. High Rac Activity in Pancreatic Tumors
(A) Rac activity is stimulated by PMA in Rac-FRETmouse pancreas ex vivo. From the left, panels show a fluorescence image of freshly isolated pancreatic tissue,
an enlargement of the region analyzed, with Raichu-Rac expression in blue and SHG signal from host ECM in white, a corresponding Rac activity (fluorescence
lifetime) map, and images of Rac activity before (top) and after (bottom) treatment with 200 nM PMA for 15 min.
(B) Quantification of pancreatic Rac activity (fluorescence lifetime;mean ±SE) as in (A) from 30 cells in three regions before and after stimulation with 200 nMPMA
for 15 min. *p < 0.05 by unpaired Student’s t test. ns, not significant.
(C) Increased Rac activity in pancreatic tumors in vivo. Representative FLIM-FRET images comparing normal pancreas in live Rac-FRET mice and pancreatic
tumors in live KPC Rac-FRETmice. For each pair of images, the left-hand panel shows a representative fluorescence image of Raichu-Rac (blue) and SHG signal
from host ECM (white), the right-hand one a corresponding FLIM-FRET fluorescence lifetime map.
(D) Quantification of Rac activity in Rac-FRET and KPC Rac-FRET pancreas in vivo as in (C). Mean fluorescence lifetime ± SEM of 222 Rac-FRET and 461 KPC
Rac-FRET cells from three to four regions/mouse, three mice/genotype. ***p < 0.001 by unpaired Student’s t test.2007) could be used in the future to express Raichu-Rac specif-
ically in stem cells of the small intestine to investigate further the
increased Rac activity we observed upon deletion of the tumor
suppressor APC. Alternatively, the Rac-FRET mouse could be
crossed to a strain expressing a red fluorescent protein specif-
ically in a cell type of interest, for in vivo colabeling and
comparing Rac activity between specific cell types within com-
plex tissues. We also crossed Rac-FRETfl/fl with Cre-ERT2 mice
for drug-inducible expression (Feil et al., 1996). Cre-ER+/T2
Rac-FRET+/fl neutrophils expressed similar levels of Raichu-
Rac upon tamoxifen treatment than Rac-FRET neutrophils and
showed normal cell responses. Thus, inducible Raichu-Rac
expression is another useful feature of the Rac-FRETfl/fl strain.
Crossing the Rac-FRET mouse to various models of disease
has demonstrated its utility for assessing the effects ofmutations
that recapitulate human disease etiology on Rac activity in a
time- and tissue-specific manner, even in organs and tissues
that contain complex mixtures of cell types, without affecting tis-
sue homeostasis. For example, in colorectal cancer, APC loss
often leads to hyperproliferation of intestinal stem cells, and
RAC1 is a critical mediator of this process through its roles in
ROS production and NF-kB signaling (Myant et al., 2013). There-
fore, it is unsurprising that we found the Rac pathway to be active
upon APC loss. We suspect that, in normal intestinal tissue, the
basal and PMA-stimulated Rac activities were also higher in cells
at the base of crypts than in distal cells because the highly pro-
liferative intestinal stem cells are located there. As anotherCeexample for possible future applications, crossing the Rac-
FRET mouse with Tyr-Cre strain for melanoblast-specific
expression (Delmas et al., 2003), with Prex1/mice or with mu-
rine models of melanoma, could provide insights into the cell-
type- and stage-specific roles of Rac deregulation during mela-
noma progression (Li et al., 2011; Lindsay et al., 2011).
Ratiometric FRET microscopy was useful for measurement of
Rac activity in isolated primary Rac-FRET neutrophils andMEFs.
Similarly, ratiometric FRET was chosen in Rac-FRET reporter-
expressing zebrafish embryos, because of their optical transpar-
ency (Kardash et al., 2010; Xu et al., 2012). In thick tissue or
organ sections, multiphoton FLIM-FRET imaging allowed us to
monitor tissues at depth and with high resolution, both ex vivo
and in vivo, in the context of the host tissue and environmental
cues. Considering recent advances in imaging and image
analysis, which allow millisecond resolution of spatiotemporal
dynamics (Hinde et al., 2013), it should be possible to adapt
imaging systems to analyze Rac activity alongside Rac-depen-
dent cell responses in any type of tissue.
Use of the Rac-FRET mouse allowed us to observe the exqui-
site spatiotemporal regulation of Rac activity in primary neutro-
phils, which are very different from even their closest model
cell lines, e.g., in their formation of more-transient and probing
lamellipodial protrusions during chemotaxis, which we show
here to be accompanied by equally transient and locally
restricted bursts of Rac activity. During the initial phase of
neutrophil spreading, we observed some increase in Racll Reports 6, 1153–1164, March 27, 2014 ª2014 The Authors 1161
Figure 7. Rac Activity in Mammary Tumors Is Inhibited by NSC23766
(A) Rac activity in PyMT Rac-FRET mouse mammary tumors is inhibited by NSC23766 ex vivo. Representative FLIM-FRET images of freshly isolated mammary
tumors of PyMTRac-FRETmice without (left) or with (right) treatment with 50 mMNSC23766 for 60min ex vivo. For each pair of images, the left-hand panel shows
a representative fluorescence image of tissue expressing Raichu-Rac (blue) and SHG signal from host ECM (white), the right-hand one a corresponding Rac
activity (fluorescence lifetime) map.
(B) Quantification of Rac activity in PyMT mammary tumors as in (A). Mean fluorescence lifetime ± SEM of 144 control cells and 74 NSC23766-treated cells from
two to three different regions/group. ***p < 0.001 by unpaired Student’s t test.
(C) Rac activity inmammary tumors is inhibited by treatment with NSC23766 in vivo. Representative FLIM-FRET images of Rac activity in mammary tumors of live
PyMT Rac-FRET mice before (left) and 60 min after (right) intraperitoneal (i.p.) injection of NSC23766 (4 mg/kg). Order of images as in (A).
(D) Quantification of Rac activity (fluorescence lifetime; mean ± SEM) in 210 cells within mammary tumors of PyMT Rac-FRET mice in vivo 0–90 min after i.p.
injection of NSC23766. **p < 0.01 and ***p < 0.001 by unpaired Student’s t test.activity, even in NSC23766-treated cells (though lower than in
controls). This could simply be due to incomplete inhibition, but
it is also possible that NSC23766-insensitive Rac-GEFs might
contribute to this phase. Rac-GEFs from the Vav family, for
example, are nonresponsive to NSC23766 (Gao et al., 2004)
and known to be required for neutrophil spreading (Lawson
et al., 2011). This possibility could be investigated in the future
by analysis of Rac-FRET neutrophils with added Rac-GEF
deficiencies. During neutrophil chemotaxis, we observed unex-
pectedbehaviors ofRacactivity in addition to theexpected accu-
mulation at the leading edge, including a retrograde shift during
stalling phases and a yo-yoing between the front and back of
the cell. It is unsurprising that these phenomena have not been
observed previously, as only a combination of FRET technology
and the use of primary cells affords sufficient spatiotemporal res-
olution. Wider and slower waves of Rac activity had previously
been observed in HL60 cells (Weiner et al., 2007), and it seems
possible that the oscillations in primary cells are mechanistically
related. It will be interesting to determine if specific upstream reg-
ulators mediate these oscillations and if these Rac-GEFs are
required for the fast migration mode of neutrophils.
Different types of small G proteins of the Rho family are
activated dependently of each other. Combined use of Rac,
CDC42, or RHOA activity probes and high-resolution imaging
of single-membrane protrusions showed that RhoA is activated
at the tip of forming cell protrusions whereas Rac and CDC421162 Cell Reports 6, 1153–1164, March 27, 2014 ª2014 The Authorsactivity patterns are wider (Machacek et al., 2009). Furthermore,
transplantation of glioblastoma cells expressing Rac, CDC42, or
RHOA reporters into rat brain suggested that the balance of Rac,
CDC42, and RHOA activities dictates modes of cancer cell inva-
sion (Hirata et al., 2012). Transgenic biosensormice for a number
of different types of small G proteins are currently being gener-
ated (Goto et al., 2013), although not as conditional alleles and
at much higher expression levels. Such GTPase reporter mice
will facilitate future comparisons between different small G pro-
teins tremendously, and different strains will doubtless prove
appropriate for different applications.
In conclusion, the Rac-FRET mouse strain has enabled us to
monitor the intricate and dynamic regulation of the small G pro-
tein Rac, an essential controller of distinct biological responses
depending on timing, location, and signaling context. Future
use of the Rac-FRET mouse as a tool, alone or in combination
with deficiencies in Rac-GEFs, Rac-GAPs, or other upstream
regulators, should fundamentally advance our insight into the
signaling networks that drive Rac-dependent cell responses
and enable us to expand our knowledge of Rac signaling in pri-
mary cells and complex multicellular physiological and disease
states.EXPERIMENTAL PROCEDURES
Detailed protocols can be found in Supplemental Experimental Procedures.
Generation of the Rac-FRET Reporter Mouse Strain
Modified Raichu-1011X plasmid (Itoh et al., 2002) was introduced into stop-
eGFP-ROSA26TV (Addgene 11739) to generate the Rac-FRET targeting
vector. Upon germline transmission, Rac-FRETfl/fl strain was crossed with
deleter to induce ubiquitous expression of Raichu-Rac. The resulting homozy-
gous Rac-FRETKi/Ki knockin mouse strain was called Rac-FRET for brevity.
Raichu-Rac expression in cells and tissues of the Rac-FRETmousewas deter-
mined by western blotting.
Rac-FRET MEF and Neutrophil Isolation and Responses
Primary E13.5 MEFs were isolated upon timed mating of Rac-FRETKi/fl mice
and cultured for up to 15 days. Proliferation assays were done by cell counting,
cell cycle assays by propidium iodide staining, and morphology assays by
image analysis of tetramethylrhodamine isothiocyanate-phalloidin-stained
cells. Primary neutrophils were freshly isolated from bone marrow for each
experiment. Adhesion and spreading were assayed on glass or integrin-ligand
surfaces, ROS formation by luminol assay, and chemotaxis by transwell
assays using 3 mm pore filters (Lawson et al., 2011; Welch et al., 2005) or Ibidi
chamber assays using Ibidi sticky slide IV0.4. Endogenous Rac activity was
determined in Rac-FRET MEF and neutrophil lysates by Pak-CRIB pull-
down and p38MAPK phosphorylation by western blotting.
Tissues and Mouse Strains for Analysis of Rac Activity in Live
Tissues and Organs
Intestinal crypt cultures (Sato et al., 2009) and skin explants (Mort et al., 2010)
were prepared as described. Vil-Cre-ERT2 APCfl/fl Rac-FRET mice for imaging
of Rac activity in intestinal crypts following APC loss, KPC Rac-FRET mice for
imaging of Rac activity in pancreatic tumors, PyMT Rac-FRET mice for
imaging of Rac activity in mammary tumors, and K14-Cre Rac-FRETfl/fl mice
for tissue-specific expression of Raichu-Rac and imaging of Rac activity in
embryonic skin were generated as detailed in Supplemental Experimental
Procedures.
Imaging
Rac activity was assessed in Rac-FRET MEFs and neutrophils by ratiometric
FRET imaging using an Olympus Cell^ R imaging system. Pairs of images
were acquired sequentially every 15 s for spreading neutrophils and every
10 s for MEFs. For chemotaxing neutrophils, both channels were acquired
simultaneously at 1 frame/s and cells tracked using ImageJ plugin QuimP11.
Pearson’s correlation was used to analyze the time dependence between
Rac activity and speed of cell edge movement and polar plots (Ferguson
et al., 2007) for the spatiotemporal representation of Rac activity at the cell
perimeter. In addition, line scans of Rac activity were performed along the
central longitudinal axis.
Imaging of Rac activity in various intact tissues and organs was done using
multiphoton FLIM-FRET imaging. Crypt cultures were imaged at depths of
0–100 mm and freshly isolated ex vivo crypts (Myant et al., 2013) at
0–150 mm. For in vivo imaging of intestinal, pancreas, or mammary tissue,
mice were terminally anesthetized. Multiphoton FLIM-FRET imaging was car-
ried out on a Nikon Eclipse TE2000-U inverted microscope with an Olympus
long working distance 20 3 0.95 numerical aperture water immersion lens
using a scan head specifically designed for multiphoton excitation. Data
were analyzed using the time-correlated single-photon counting fluorescence
lifetime analysis functionality of ImSpectorPro (LaVison Biotec).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and eight movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.02.024.
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